نتائج البحث - "Amelia Zelnak"

1

Supplementary Table from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

المؤلفون: Stacy Moulder, Das Purkayastha, Hope S. Rugo, Cynthia Ma, Lowell Hart, Sibel Blau, Tara Sanft, Meghan Karuturi, Denise A. Yardley, Amelia Zelnak, Amy S. Clark, Angela DeMichele, Sara A. Hurvitz, Aditya Bardia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f79162e403f52cd2827f8f30f5dab00
https://doi.org/10.1158/1078-0432.22480703.v1

2

Supplementary ctDNA Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

المؤلفون: Stacy Moulder, Das Purkayastha, Hope S. Rugo, Cynthia Ma, Lowell Hart, Sibel Blau, Tara Sanft, Meghan Karuturi, Denise A. Yardley, Amelia Zelnak, Amy S. Clark, Angela DeMichele, Sara A. Hurvitz, Aditya Bardia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5502b491810b2c3807132692ff9904ac
https://doi.org/10.1158/1078-0432.22480697

3

Data from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

المؤلفون: Stacy Moulder, Das Purkayastha, Hope S. Rugo, Cynthia Ma, Lowell Hart, Sibel Blau, Tara Sanft, Meghan Karuturi, Denise A. Yardley, Amelia Zelnak, Amy S. Clark, Angela DeMichele, Sara A. Hurvitz, Aditya Bardia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f70b18e05e6e18e7fadac82839c4c0a
https://doi.org/10.1158/1078-0432.c.6530513

4

Suppl Figure from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

المؤلفون: Stacy Moulder, Das Purkayastha, Hope S. Rugo, Cynthia Ma, Lowell Hart, Sibel Blau, Tara Sanft, Meghan Karuturi, Denise A. Yardley, Amelia Zelnak, Amy S. Clark, Angela DeMichele, Sara A. Hurvitz, Aditya Bardia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a86d3037488025a711951040a9c8f7
https://doi.org/10.1158/1078-0432.22480706.v1

5

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

المساهمون: Institut Català de la Salut, [Lin NU] Dana-Farber Cancer Institute, Boston, Massachusetts. [Murthy RK] MD Anderson Cancer Center, Houston, Texas. [Abramson V] Vanderbilt University Medical Center, Nashville, Tennessee. [Anders C] Duke Cancer Institute, Durham, North Carolina. [Bachelot T] Centre Léon Bérard, Lyon, France. [Bedard PL] University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. [Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
U. Lin, N, K. Murthy, R, Abramson, V, Anders, C, Bachelot, T, L. Bedard, P, Borges, V, Cameron, D A, A. Carey, L, Chien, J, Curigliano, G, P. Di Giovanna, M, Gelmon, K, Hortobagyi, G, A. Hurvitz, S, Krop, I, Loi, S, Loibl, S, Mueller, V, Oliveira, M, Paplomata, E, Pegram, M, Slamon, D, Zelnak, A, Ramos, J, Feng, W & Winer, E 2022, ' Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain MetastasesUpdated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2022.5610

مصطلحات موضوعية: Cancer Research, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], neoplasias::neoplasias por localización::neoplasias del sistema nervioso::neoplasias del sistema nervioso central::neoplasias cerebrales [ENFERMEDADES], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Quimioteràpia combinada, Medicaments antineoplàstics - Efectes secundaris, Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms::Brain Neoplasms [DISEASES], Oncology, Metàstasi, Cervell - Càncer - Tractament, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Mama - Càncer - Tractament, Other subheadings::Other subheadings::/adverse effects [Other subheadings]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f800399cc04de7baef3960b16afc0f9b
https://hdl.handle.net/11351/9527

6

Abstract P5-16-07: Assessment of sacituzumab govitecan (SG) in Black patients (pts) from the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC)

المصدر: Cancer Research. 82:P5-16

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6e1dddc996c091045eee8ac388ffc48a
https://doi.org/10.1158/1538-7445.sabcs21-p5-16-07

7

Using Oncotype DX Breast Recurrence Score® Assay to Define the Role of Neoadjuvant Endocrine Therapy in Early-Stage Hormone Receptor-Positive Breast Cancer

المؤلفون: Caitlin Taylor, Jane Meisel, Aimee J. Foreman, Christy Russell, Dipankar Bandyopadhyay, Xiaoyan Deng, Lisa Floyd, Amelia Zelnak, Harry Bear, Ruth O’Regan

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83b8a1128726571c675738adb05ddd35
https://doi.org/10.21203/rs.3.rs-2228265/v1

8

Abstract GS3-06: Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

المصدر: Cancer Research. 81:GS3-06

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f775a95f47fb7f11c04bcf4bbfa9b2f0
https://doi.org/10.1158/1538-7445.sabcs20-gs3-06

9

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

المساهمون: Institut Català de la Salut, [Lin NU] Dana-Farber Cancer Institute, Boston, MA, USA. [Borges V] University of Colorado Cancer Center, Aurora, CO, USA. [Anders C] Duke Cancer Institute, Durham, NC, USA. [Murthy RK] MD Anderson Cancer Center, Houston, TX, USA. [Paplomata E] Carbone Cancer Center/University of Wisconsin, Madison, WI, USA. [Hamilton E] Sarah Cannon Research Institute/Tennessee Oncology–Nashville, Nashville, TN, USA. [Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Journal of Clinical Oncology
Scientia
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 23
Lin, N U, Borges, V, Anders, C, Murthy, R K, Paplomata, E, Hamilton, E, Hurvitz, S, Loi, S, Okines, A, Abramson, V, Bedard, P L, Oliveira, M, Mueller, V, Zelnak, A, Digiovanna, M P, Bachelot, T, Chien, A J, O’regan, R, Wardley, A, Conlin, A, Cameron, D, Carey, L, Curigliano, G, Gelmon, K, Loibl, S, Mayor, J, Mcgoldrick, S, An, X & Winer, E P 2020, ' Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial ', Journal of Clinical Oncology, pp. JCO.20.00775 . https://doi.org/10.1200/JCO.20.00775, https://doi.org/10.1200/JCO.20.00775
BASE-Bielefeld Academic Search Engine

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Pyridines, Receptor, ErbB-2, medicine.medical_treatment, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], law.invention, ErbB-2, 0302 clinical medicine, Randomized controlled trial, Mama - Càncer, law, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Other subheadings::/therapeutic use [Other subheadings], Young adult, Oxazoles, Cancer, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Brain Neoplasms, Middle Aged, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Disease Progression, Female, Receptor, medicine.drug, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Breast Neoplasms, Capecitabine, 03 medical and health sciences, Young Adult, Breast cancer, Double-Blind Method, Clinical Research, Internal medicine, RAPID COMMUNICATIONS, Breast Cancer, medicine, Humans, Oncology & Carcinogenesis, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Aged, Medicaments antineoplàstics - Ús terapèutic - Eficàcia, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], Neurosciences, Evaluation of treatments and therapeutic interventions, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Radiation therapy, 030104 developmental biology, Clinical research, Quinazolines, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50a61cdbadd64177752d4282725713e
http://europepmc.org/articles/PMC7403000

10

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

المساهمون: Institut Català de la Salut, [Bardia A] Massachusetts General Hospital, Harvard Medical School, Boston, USA. [Tolaney SM] Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. [Punie K] Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. [Loirat D] Medical Oncology Department and D3i, Institut Curie, Paris, France. [Oliveira M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Kalinsky K] Columbia University Irving Medical Center, New York, USA. Winship Cancer Institute, Emory University, Atlanta, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Annals of oncology
Scientia

مصطلحات موضوعية: 0301 basic medicine, Oncology, Immunoconjugates, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], medicine.medical_treatment, BRCA, Triple Negative Breast Neoplasms, Other subheadings::Other subheadings::/drug therapy [Other subheadings], chemistry.chemical_compound, 0302 clinical medicine, Other subheadings::/therapeutic use [Other subheadings], TROP-2, Triple-negative breast cancer, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], medicine.diagnostic_test, Hematology, 030220 oncology & carcinogenesis, triple-negative breast cancer, Life Sciences & Biomedicine, medicine.drug, Eribulin, medicine.medical_specialty, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Antibodies, Monoclonal, Humanized, Vinorelbine, trophoblast cell-surface antigen 2, Capecitabine, 03 medical and health sciences, Breast cancer, Internal medicine, Biopsy, IMMU-132, medicine, Humans, Chemotherapy, Science & Technology, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::globulinas séricas::inmunoglobulinas::anticuerpos::inmunoconjugados [COMPUESTOS QUÍMICOS Y DROGAS], Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Serum Globulins::Immunoglobulins::Antibodies::Immunoconjugates [CHEMICALS AND DRUGS], Immunoglobulines - Ús terapèutic, medicine.disease, Gemcitabine, Cancérologie, 030104 developmental biology, chemistry, Mama - Càncer - Tractament, Marcadors bioquímics - Anàlisi, Camptothecin, business, Biomarkers, ANTIBODY-DRUG CONJUGATE, Hématologie

وصف الملف: Print-Electronic; 1 full-text file(s): application/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7674f8ee6f826048de62dac913e752f3
https://lirias.kuleuven.be/handle/20.500.12942/686442

تنقيح النتائج